<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01197612</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00029273</org_study_id>
    <nct_id>NCT01197612</nct_id>
  </id_info>
  <brief_title>Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis</brief_title>
  <official_title>Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Rhinologic Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      That high-dose steroid applied to the nasal cavity immediately post-operatively will improve
      olfaction and healing following endoscopic sinus surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2010</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Olfaction</measure>
    <time_frame>3 weeks post-operation</time_frame>
    <description>will be measured with the University of Pennsylvania Smell Identification Test (UPSIT), whose scores range from 0 to 40, where 0 is the inability to smell anything and 40 is perfect smell identification</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sinonasal Health</measure>
    <time_frame>3 weeks post operation</time_frame>
    <description>will be assessed with the Perioperative Sinus Endoscopy score (POSE), a 20 point scale where 0 is no sinus challenges and 20 represents the greatest blockage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Olfaction</measure>
    <time_frame>24 weeks post operation</time_frame>
    <description>Scored with the University of Pennsylvania Smell Identification Test, whose scores range from 0 to 40, where 0 is the inability to smell anything and 40 is perfect smell identification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sinonasal Health</measure>
    <time_frame>24 weeks post operation</time_frame>
    <description>Assessed with Perioperative Sinus Endoscopy (POSE) score</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Chronic Sinusitis</condition>
  <condition>Polyposis</condition>
  <arm_group>
    <arm_group_label>Single Arm; nostrils as experimental and comparator</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>each subject serves as their own control with one nostril being treated with pulmicort and one not</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pulmicort</intervention_name>
    <description>applied to nasal packing after surgery</description>
    <arm_group_label>Single Arm; nostrils as experimental and comparator</arm_group_label>
    <other_name>budesonide</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hyposmia and nasal obstruction for &gt;12 weeks

          -  bilateral nasal polyposis

          -  candidate for surgery

        Exclusion Criteria:

          -  immunocompromised

          -  non-English speaking

          -  prisoner

          -  pregnant/lactating

          -  will not attend follow up appointments
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Garrett R Griffin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2010</study_first_submitted>
  <study_first_submitted_qc>September 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2010</study_first_posted>
  <results_first_submitted>April 24, 2018</results_first_submitted>
  <results_first_submitted_qc>April 24, 2018</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 28, 2018</results_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Garrett Griffin</investigator_full_name>
    <investigator_title>Resident/Research Fellow</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Nasopharyngeal Neoplasms</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Budesonide</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of 23 participants who consented, data is only available for 20. Two never had surgery, and so were not &quot;assigned&quot; at all.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Single Arm; Nostrils as Experimental and Comparator</title>
          <description>each subject serves as their own control with one nostril being treated with pulmicort and one not
pulmicort: applied to nasal packing after surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 3</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Returned for Week 24</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Single Arm; Nostrils as Experimental and Comparator</title>
          <description>each subject serves as their own control with one nostril being treated with pulmicort and one not
pulmicort: applied to nasal packing after surgery</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="18"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Olfaction</title>
        <description>will be measured with the University of Pennsylvania Smell Identification Test (UPSIT), whose scores range from 0 to 40, where 0 is the inability to smell anything and 40 is perfect smell identification</description>
        <time_frame>3 weeks post-operation</time_frame>
        <population>Of sixteen participants at the three week mark, one participant's data was unable to be unblinded accurately, and one participant had no UPSIT scores taken, leaving an analysis population of 14,</population>
        <group_list>
          <group group_id="O1">
            <title>Treated Nostril (Pulmicort)</title>
            <description>each subject serves as their own control with one nostril being treated with pulmicort and one not
pulmicort: applied to nasal packing after surgery</description>
          </group>
          <group group_id="O2">
            <title>Untreated Nostril (no Pulmicort)</title>
            <description>each subject serves as their own control with one nostril being treated with pulmicort and one not
pulmicort: applied to nasal packing after surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Olfaction</title>
          <description>will be measured with the University of Pennsylvania Smell Identification Test (UPSIT), whose scores range from 0 to 40, where 0 is the inability to smell anything and 40 is perfect smell identification</description>
          <population>Of sixteen participants at the three week mark, one participant's data was unable to be unblinded accurately, and one participant had no UPSIT scores taken, leaving an analysis population of 14,</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.2" lower_limit="8" upper_limit="36"/>
                    <measurement group_id="O2" value="19.8" lower_limit="6" upper_limit="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sinonasal Health</title>
        <description>will be assessed with the Perioperative Sinus Endoscopy score (POSE), a 20 point scale where 0 is no sinus challenges and 20 represents the greatest blockage.</description>
        <time_frame>3 weeks post operation</time_frame>
        <population>unblinding could not be done on one person accurately, so only 15 rather than 16 people's data could be analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Treated Nostril (Pulmicort)</title>
            <description>each subject serves as their own control with one nostril being treated with pulmicort and one not
pulmicort: applied to nasal packing after surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo Treated Nostril (no Pulmicort)</title>
            <description>each subject serves as their own control with one nostril being treated with pulmicort and one not
pulmicort: applied to nasal packing after surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Sinonasal Health</title>
          <description>will be assessed with the Perioperative Sinus Endoscopy score (POSE), a 20 point scale where 0 is no sinus challenges and 20 represents the greatest blockage.</description>
          <population>unblinding could not be done on one person accurately, so only 15 rather than 16 people's data could be analyzed</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" lower_limit="1" upper_limit="10"/>
                    <measurement group_id="O2" value="4.7" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Olfaction</title>
        <description>Scored with the University of Pennsylvania Smell Identification Test, whose scores range from 0 to 40, where 0 is the inability to smell anything and 40 is perfect smell identification</description>
        <time_frame>24 weeks post operation</time_frame>
        <population>Of six participants remaining at 24 weeks, one participant's data could not be accurately unblinded leaving analysis of 5</population>
        <group_list>
          <group group_id="O1">
            <title>Treated Nostril (Pulmicort)</title>
            <description>each subject serves as their own control with one nostril being treated with pulmicort and one not
pulmicort: applied to nasal packing after surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo/Untreated Nostril (no Pulmicort)</title>
            <description>each subject serves as their own control with one nostril being treated with pulmicort and one not
pulmicort: applied to nasal packing after surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Olfaction</title>
          <description>Scored with the University of Pennsylvania Smell Identification Test, whose scores range from 0 to 40, where 0 is the inability to smell anything and 40 is perfect smell identification</description>
          <population>Of six participants remaining at 24 weeks, one participant's data could not be accurately unblinded leaving analysis of 5</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.4" lower_limit="9" upper_limit="37"/>
                    <measurement group_id="O2" value="20" lower_limit="7" upper_limit="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sinonasal Health</title>
        <description>Assessed with Perioperative Sinus Endoscopy (POSE) score</description>
        <time_frame>24 weeks post operation</time_frame>
        <population>Of six participants at 24 weeks, one's data was unable to be unblinded accurately, leaving an analysis population of 5 participants</population>
        <group_list>
          <group group_id="O1">
            <title>Treated Nostril (Pulmicort)</title>
            <description>each subject serves as their own control with one nostril being treated with pulmicort and one not
pulmicort: applied to nasal packing after surgery</description>
          </group>
          <group group_id="O2">
            <title>Untreated Nostril (no Pulmicort)</title>
            <description>each subject serves as their own control with one nostril being treated with pulmicort and one not
pulmicort: applied to nasal packing after surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Sinonasal Health</title>
          <description>Assessed with Perioperative Sinus Endoscopy (POSE) score</description>
          <population>Of six participants at 24 weeks, one's data was unable to be unblinded accurately, leaving an analysis population of 5 participants</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" lower_limit="0" upper_limit="11"/>
                    <measurement group_id="O2" value="5.6" lower_limit="2" upper_limit="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Single Arm; Nostrils as Experimental and Comparator</title>
          <description>each subject serves as their own control with one nostril being treated with pulmicort and one not
pulmicort: applied to nasal packing after surgery</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This was a pilot study with less enrollment than desired and poor rate of completion with only 5 participants completing the full 24 week trial. This study could be done on a larger/similar scale with some additional useful data obtained.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Garrett Griffin, MD</name_or_title>
      <organization>University of Michigan</organization>
      <email>ggriffin@mw-fp.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

